Literature DB >> 14632809

A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months.

N Wadonda-Kabondo1, J A C Sterne, J Golding, C T C Kennedy, C B Archer, M G S Dunnill.   

Abstract

BACKGROUND: There is strong evidence that the incidence and prevalence of atopic diseases is increasing. However, estimates of the prevalence of atopic dermatitis (AD) have varied greatly in the U.K. and most parts of the developed world.
OBJECTIVES: The aim of the study was to estimate the prevalence and incidence of AD between the ages of 0 and 42 months in children born in the 1990s in a defined population in the U.K.
DESIGN: We used data from the Avon Longitudinal Study of Pregnancy and Childhood (ALSPAC), a large population-based study in the U.K. that enrolled all pregnant mothers who were resident in Avon and had their delivery date falling between 1 April 1991 and 31 December 1992. Since then ALSPAC has collected a wide range of data from the newborns and their parents. Data reported here were collected at 6, 18, 30 and 42 months using parental reports in a postal questionnaire. Of the 14 009 children originally enrolled 8530 provided information on AD in each of the four follow-up questionnaires. We defined AD as a report of rash in at least two of the four questionnaires. Incidence risk was defined as the percentage of new cases of AD between follow-up questionnaires, out of the total number of children whose parents had not reported that they had AD by the time of the previous follow-up.
RESULTS: Period prevalence of 21.0%, 25.6%, 23.2% and 19.9% were observed at ages 0-6, 6-18, 18-30 and 30-42 months, respectively. The corresponding incidence risks were 21.0%, 11.2% and 3.8%, at 0-6, 6-18 and 18-30 months, respectively. There were no gender differences in either the incidence or prevalence of the disease.
CONCLUSIONS: Results from this large, prospective study are consistent with recent reports of increased incidence and prevalence of AD. Health planners can use our estimates of incidence and prevalence to project the number of children likely to suffer from AD during infancy and early childhood, and thus to determine the human and financial resources required.

Entities:  

Mesh:

Year:  2003        PMID: 14632809     DOI: 10.1111/j.1365-2133.2003.05605.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  Effects of probiotics on atopic dermatitis: a randomised controlled trial.

Authors:  S Weston; A Halbert; P Richmond; S L Prescott
Journal:  Arch Dis Child       Date:  2005-04-29       Impact factor: 3.791

2.  Effect of prenatal exposure to fine particulate matter and intake of Paracetamol (Acetaminophen) in pregnancy on eczema occurrence in early childhood.

Authors:  Wieslaw Jedrychowski; John D Spengler; Umberto Maugeri; Rachel L Miller; Dorota Budzyn-Mrozek; Matt Perzanowski; Elzbieta Flak; Elzbieta Mroz; Renata Majewska; Irena Kaim; Frederica Perera
Journal:  Sci Total Environ       Date:  2011-10-01       Impact factor: 7.963

3.  Effects of prenatal and perinatal exposure to fine air pollutants and maternal fish consumption on the occurrence of infantile eczema.

Authors:  Wieslaw Jedrychowski; Frederica Perera; Umberto Maugeri; Dorota Mrozek-Budzyn; Rachel L Miller; Elzbieta Flak; Elzbieta Mroz; Ryszard Jacek; John D Spengler
Journal:  Int Arch Allergy Immunol       Date:  2011-02-03       Impact factor: 2.749

Review 4.  Prevention or acceleration of type 1 diabetes by viruses.

Authors:  Liana Ghazarian; Julien Diana; Yannick Simoni; Lucie Beaudoin; Agnès Lehuen
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study.

Authors:  N Wadonda-Kabondo; J A C Sterne; J Golding; C T C Kennedy; C B Archer; M G S Dunnill
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

Review 6.  The atopic march: what's the evidence?

Authors:  Jennifer Ker; Tina V Hartert
Journal:  Ann Allergy Asthma Immunol       Date:  2009-10       Impact factor: 6.347

7.  Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise.

Authors:  S J Brown; S M Langan; S G Nicholls; K Shams; E Healy; N J Reynolds
Journal:  Br J Dermatol       Date:  2015-10-14       Impact factor: 9.302

8.  The role of allergic risk and other factors that affect the occurrence of atopic dermatitis in the first 6 months of life.

Authors:  Zakiudin Munasir; Sudigdo Sastroasmoro; Samsuridjal Djauzi; Sarwono Waspadji; Wahyuning Ramelan; Asril Aminullah; Retno Widowati; Alida Roswita Harahap; Anang Endaryanto; Iskandar Wahidiyat
Journal:  Asia Pac Allergy       Date:  2011-07-28

9.  The Mothers and Children's Environmental Health (MOCEH) study.

Authors:  Byung-Mi Kim; Mina Ha; Hye-Sook Park; Bo Eun Lee; Young Ju Kim; Yun-Chul Hong; Yangho Kim; Namsoo Chang; Young-Man Roh; Boong-Nnyun Kim; Se-young Oh; Eun-Hee Ha
Journal:  Eur J Epidemiol       Date:  2009-07-24       Impact factor: 8.082

10.  Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis.

Authors:  Chunyun Huang; Youyu Sheng
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.